CCL3 and osteosarcoma: The immunohistochemistry (IHC) result indicated that CCL3 expression is higher in osteosarcoma patients compared to normal individuals, and the expression profile of CCL3 is associated with the osteosarcoma clinical stage (Fig. 1A).